Proteome-wide

Omni 1000

Delivering deep biological insight with absolute quantification across 1,000 expertly selected proteins — balancing comprehensive pathway coverage, clinical relevance, and discovery-ready utility.

Get started

Unmatched Coverage, Built for Discovery

92%

of Most Valuable Proteins

100%

Level 0 Reactome Coverage

80%

Level 1 reactome coverage

100%

MSH Disease Classes

100%

KEGG Drug Discovery Pathways

95%

Disease Prediction Power

Download the app note

The Most Informative 1000 Proteins

Explore the nELISA Library

List of targets in the nELISA Library.

Filters
Clear all
Showing 0 of 100
Product
Clear
Reactome Level 0
Clear
KEGG Pathway
Clear
Cellular Location
Clear
Reactome Level 0
Clear
Clear all
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Target Name
Uniprot ID
Gene Names
filter-tests
‍
No items found.

Download the full target list

Download here
flex
Core Immume
Core CardioMet
Omni
Vesicle-mediated transport
Transport of small molecules
Sensory Perception
Signal Transduction
Reproduction
Metabolism of proteins
Protein localization
Programmed Cell Death
Muscle contraction
Neuronal System
Organelle biogenesis and maintenance
Hemostasis
Metabolism of RNA
Metabolism
DNA Repair
Immune System
Gene expression (Transcription)
Developmental Biology
Extracellular matrix organization
Drug ADME
Disease
Digestion and absorption
Circadian Clock
Chromatin organization
Autophagy
Cellular responses to stimuli
Cell-Cell communication
Cell Cycle
6.12 Drug resistance: antineoplastic
6.10 Endocrine and metabolic disease
6.9 Cardiovascular disease
6.4 Infectious disease: bacterial
6.6 Immune disease
6.8 Substance dependence
6.7 Neurodegenerative disease
6.5 Infectious disease: parasitic
6.3 Infectious disease: viral
6.2 Cancer: specific types
6.1 Cancer: overview
5.10 Environmental adaptation
5.9 Aging
5.8 Development and regeneration
5.6 Nervous system
5.7 Sensory system
5.5 Excretory system
5.1 Immune system
1.11 Xenobiotics biodegradation and metabolism
4.2 Cell growth and death
5.4 Digestive system
5.2 Endocrine system
5.3 Circulatory system
4.1 Transport and catabolism
4.5 Cell motility
4.3 Cellular community - eukaryotes
3.3 Signaling molecules and interaction
3.2 Signal transduction
3.1 Membrane transport
2.6 Information processing in viruses
2.5 Chromosome
2.4 Replication and repair
1.8 Metabolism of cofactors and vitamins
2.3 Folding, sorting and degradation
2.2 Translation
2.1 Transcription
1.7 Glycan biosynthesis and metabolism
1.10 Biosynthesis of other secondary metabolites
1.3 Lipid metabolism
1.4 Nucleotide metabolism
1.6 Metabolism of other amino acids
1.9 Metabolism of terpenoids and polyketides
1.0 Global and overview maps
1.2 Energy metabolism
1.1 Carbohydrate metabolism
1.5 Amino acid metabolism
Cell Membrane
Nucleus
Secreted
Cytoplasm
Tech note

The nELISA: A Massively Multiplexed & Miniaturized Immunoassay Platform for High-Throughput Protein Profiling

The nELISA brings a quantum leap to protein profiling by enabling the scaling of content without the need to compromise on throughput or cost. By enabling scientists to measure more proteins in more samples for less, Nomic is supporting new discoveries and accelerating the development of new drugs and diagnostics.

Download Tech Note

Resources

All Resources
Application Note
Nomic Bio
•
November 1, 2024

The nELISA: A Massively Multiplexed & Miniaturized Immunoassay Platform for High-Throughput Protein Profiling

How nELISA miniaturizes immunoassays on beads, overcoming reagent-driven cross-reactivity and reducing costs.
Read more
Publication
Milad Dagher & David Juncker
•
April 18, 2023

nELISA: A high-throughput, high-plex platform enables quantitative profiling of the secretome

BioRxiv ; We present the nELISA, a miniaturised, high-throughput, and high-fidelity protein profiling platform.
Read more
White Paper
Nomic Bio
•
October 16, 2024

True Multiplexing with the nELISA

True Multiplexing Unlocks Scalable Proteomics
Read more
Application Note
Nomic Bio
•
January 14, 2025

Using the nELISA™ to Map Cytokine Interactions in a 10,000-well PBMC Perturbation Screen

High-throughput protein profiling technology enables comprehensive and quantitative mapping of cytokine interactions
Read more
News
Nomic Bio
•
September 24, 2024

Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study

Project will quantify circulating protein markers in ~3000 patient blood samples from PICI’s RADIOHEAD study using Nomic’s nELISA™ high-throughput protein profiling platform to better understand how patients respond to treatment
Read more
News
Nomic Bio
•
December 8, 2021

Nomic Closes $17 Million Series A to Develop and Commercialize the World’s Highest Throughput Proteomic Platform

Nomic is closing of an oversubscribed US$17 million Series A funding round, bringing the company's total funding to date to over US$21 million.
Read more
News
Nomic Bio
•
June 28, 2023

Nomic Bio Appoints Byron Hewett to its Board of Directors

Hewett brings invaluable operational and strategic expertise to guide Nomic Bio through its crucial years of growth.
Read more
News
Nomic Bio
•
December 8, 2021

Nomic to Provide nELISA to JUMP Cell Painting Consortium to Measure Protein Secretome for Phenotypic Drug Discovery

Nomic’s nELISA will be used to profile 200 secreted proteins for ten thousand samples to provide consortium partners complementary information about the secretome
Read more
Brochure
Nomic Bio
•
January 13, 2025

How To Access the nELISA Service

Accessing our profiling service is a simple and seamless experience. We offer comprehensive, end-to-end support to help you harness the power of the proteome.
Read more
News
Nomic Bio
•
September 17, 2024

Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling

The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.
Read more
News
MIlad Dagher, CEO
•
January 3, 2025

Bridging the Gaps in Proteomics

Enabling well-powered studies, absolute quantification, and unlimited content flexibility
Read more
Read All News